Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XENITRA LIMITED Director's Dealing 2021

Jul 22, 2021

66096_rns_2021-07-22_a2acf292-bf08-4a39-909f-a603ea258465.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Aumake Ltd ABN: 79 150 110 017

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Jacky Yang
Date of last notice 17 March 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
EC Capital Pty Ltd ATF EC Capital Trust
Date of change 23 July 2021
No. of securities held prior to change
3,831,144 ordinary fully paid shares

4,034,853 ordinary fully paid shares, under
voluntary escrow until 23 July 2022
Total: 7,865,997

15,000,000
Unquoted
options
expiry
04/12/2024 exercisable @ $0.20

3,125,000 Unquoted performance rights
Class A

833,333 quoted options expiry 16/3/2024
exercisable @$0.14
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class Ordinary fully paid shares
Unquoted options
Unquoted Performance Rights
Quoted options
Number acquired 7,928,271 ordinary fully paid shares under
voluntary escrow to 23 July 2023
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
$245,776.40 (estimated valuation of non-cash
consideration)
No. of securities held after change
3,831,144 ordinary fully paid shares

4,034,853 ordinary fully paid shares, under
voluntary escrow until 23 July 2022

7,928,271 ordinary fully paid shares under
voluntary escrow to 23 July 2023
Total: 15,794,268

15,000,000
Unquoted
options
expiry
04/12/2024 exercisable @ $0.20

3,125,000 Unquoted performance rights
Class A
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
The shares have been issued as part of the
Stage 3 Equity Consideration for the Broadway
Assets, as detailed in the Notice of Meeting
lodged on 26 May 2021. The agreement to
acquire the Broadway Assets was announced
on 17 April 2019. The issue of shares was
approved by shareholders at a general
meeting on 25 June 2021.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3